We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Skyworks Solutions
SWKS
$11.2B
| $34.7M | 0.07% |
465,307
+202,205
| +77% | +$13.5M |
2013 Q2
48 quarters
|
|
327
Humana
HUM
$52.1B
| $34.5M | 0.06% |
140,956
+57,680
| +69% | +$14.4M |
2013 Q2
48 quarters
|
|
328
Citigroup
C
$221B
| $34.3M | 0.06% |
403,148
-2,461
| -0.6% | -$178K |
2013 Q2
48 quarters
|
|
329
Fair Isaac
FICO
$16B
| $34.2M | 0.06% |
18,694
+6,429
| +52% | +$12.1M |
2013 Q2
48 quarters
|
|
330
Samsara
IOT
$24.4B
| $34.1M | 0.06% |
858,266
+132,268
| +18% | +$5.47M |
2025 Q1
1 quarter
|
|
331
Public Storage
PSA
$54B
| $33.8M | 0.06% |
115,318
-9,245
| -7% | -$2.74M |
2013 Q2
48 quarters
|
|
332
Norwegian Cruise Line
NCLH
$7.05B
| $33.7M | 0.06% |
1,659,890
+210,073
| +14% | +$3.76M |
2023 Q1
9 quarters
|
|
333
SL Green Realty
SLG
$3.45B
| $33.6M | 0.06% |
543,026
+19,844
| +4% | +$1.14M |
2013 Q2
48 quarters
|
|
334
Marvell Technology
MRVL
$239B
| $33.1M | 0.06% |
427,370
-195,997
| -31% | -$12.2M |
2017 Q1
33 quarters
|
|
335
Waystar Holding Corp
WAY
$5.11B
| $32.8M | 0.06% |
801,718
+157,024
| +24% | +$6.05M |
2024 Q4
2 quarters
|
|
336
GitLab
GTLB
$9.33B
| $32.6M | 0.06% |
721,714
+130,687
| +22% | +$5.98M |
2023 Q3
7 quarters
|
|
337
Procept Biorobotics
PRCT
$1.12B
| $32.5M | 0.06% |
565,083
+25,863
| +5% | +$1.46M |
2024 Q1
5 quarters
|
|
338
IBM
IBM
$214B
| $32.4M | 0.06% |
109,813
+2,671
| +2% | +$688K |
2013 Q2
48 quarters
|
|
339
Powell Industries
POWL
$6.75B
| $32M | 0.06% |
456,354
+86,307
| +23% | +$5.21M |
2023 Q1
9 quarters
|
|
340
Willis Towers Watson
WTW
$27.7B
| $32M | 0.06% |
104,370
+1,582
| +2% | +$491K |
2016 Q1
37 quarters
|
|
341
VICI Properties
VICI
$25.4B
| $32M | 0.06% |
980,562
-239,623
| -20% | -$7.63M |
2022 Q2
12 quarters
|
|
342
Bilibili
BILI
$6.26B
| $31.8M | 0.06% |
1,480,287
+133,828
| +10% | +$2.46M |
2024 Q4
2 quarters
|
|
343
Medtronic
MDT
$118B
| $31.5M | 0.06% |
361,932
-515
| -0.1% | -$43.7K |
2013 Q2
48 quarters
|
|
344
Service Corp International
SCI
$10.6B
| $31.5M | 0.06% |
387,330
-116,253
| -23% | -$9.08M |
2013 Q2
48 quarters
|
|
345
Elanco Animal Health
ELAN
$11.3B
| $31.2M | 0.06% |
2,181,580
+15,825
| +0.7% | +$185K |
2022 Q3
11 quarters
|
|
346
Lam Research
LRCX
$387B
| $30.9M | 0.06% |
317,034
-273,816
| -46% | -$21.7M |
2013 Q2
48 quarters
|
|
347
Aflac
AFL
$58.1B
| $30.8M | 0.06% |
291,656
+287,362
| +6,692% | +$30.2M |
2013 Q2
48 quarters
|
|
348
Bio-Rad Laboratories Class A
BIO
$9.74B
| $30.7M | 0.06% |
127,058
-13,192
| -9% | -$3.12M |
2013 Q2
48 quarters
|
|
349
Microchip Technology
MCHP
$40.1B
| $30.4M | 0.06% |
431,775
+394,949
| +1,072% | +$21.7M |
2013 Q2
48 quarters
|
|
350
DELISTED
Confluent
CFLT
| $30.4M | 0.06% |
1,218,100
| – | – |
2023 Q1
9 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.